CDD3505

CAS No. 173865-33-3

CDD3505( 4-nitro-1-trityl-1H-imidazole )

Catalog No. M26553 CAS No. 173865-33-3

CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 Get Quote
10MG 140 Get Quote
25MG 254 Get Quote
50MG 377 Get Quote
100MG 537 Get Quote
500MG 1152 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CDD3505
  • Note
    Research use only, not for human use.
  • Brief Description
    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • Description
    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • In Vitro
    CDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
  • In Vivo
    ——
  • Synonyms
    4-nitro-1-trityl-1H-imidazole
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    Anti-infection| Bacterial| HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    173865-33-3
  • Formula Weight
    355.397
  • Molecular Formula
    C22H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 14.29 mg/mL (40.21 mM)
  • SMILES
    [O-][N+](=O)c1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chaudhuri S, et al. Binding of the bioflavonoid robinetin with model membranes and hemoglobin: Inhibition of lipid peroxidation and protein glycosylation. J Photochem Photobiol B. 2010 Jan 21;98(1):12-9.
molnova catalog
related products
  • Bergapten

    5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.

  • N-desmethyl Olanzapi...

    N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.

  • JNJ0966

    JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).